The pace of health innovation, powered by technology, is accelerating. AI has taken over as a key driver — and nowhere is this more critical than in medicine. From detecting markers of risk, to automating physician tasks, to pre and over-reading diagnostic reports, to clinical decision support, at MIT on September 18th, ApplySci will continue to cover AI in healthcare, and its unique connection to innovative sensors. We will explore pioneering treatments for disease, novel methods of early detection, and better approaches to brain and body health, including advances in brain computer interface.
Cardio-respiratory medicine has advanced dramatically. COVID-era advances in personalized medicine will undoubtedly help the fight against cancer. But treating the brain, with its 400 miles of blood vessels, and an epidemic of neurodegeneration, and system-wide cell deterioration, remains an enormous challenge to healthy longevity.
At the 14th ApplySci Deep Tech Health + Neurotech conference, leading researchers, technologists, entrepreneurs, investors, pharma and health system innovators, and supporting agencies, will again gather to discuss the next generation of healthcare.
Initial session topics include:
- Generative AI in healthcare
- AI in drug development, disease detection, and the doctor/patient experience
- AI in clinical decision support
- Biolectric medicine, precision medicine, and the latest approaches to gastrointestinal disease, neurodegenerative disease, diabetes, and cancer
- Novel materials for sensor-driven diagnostics, treatment, and drug delivery
- Tele – ICU
- Neuro assessment and personalized treatment of Alzheimer’s and Parkinson’s disease, autism, and mental illness, and in critical care and anesthesia
- Electric, magnetic, auditory, visual, and in the future, optogenetic brain stimulation
- Invasive and nonivasive Brain Computer Interface for paralysis, restoring brain function, and communication between the brain and the rest of the body
- Slowing, and ultimately reversing aging
- Clinical trials of the future
- Regulatory guidance
- A panel of health investors
- A panel of health-tech entrepreneurs will be selected from registered attendees
—–Stay posted as our agenda develops——
